Groin reconstruction by anterolateral thigh flap: A review of 16 cases

Autor: Ahmad Quazi, Reddy Murali, Shetty Kanti, Prasad Rajendra, Hosi J, Bhathena M

Publikováno v: Indian Journal of Plastic Surgery, Vol 37, Iss 1, Pp 34-39 (2004)

We present our experience of pedicled Anterolateral thigh flap for reconstruction of groin defects in cancer patients. Total of 17 flaps in 16 patients were performed between January 2001 to May 2003. 15 flaps were used for groin defects after node d

Externí odkaz: https://doaj.org/article/d2f7b533a64c4d28863ed6082cb059c1

FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.

Autor: Royce M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Osgood CL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amatya AK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chang CJG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ricks TK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Shetty KA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Kraft J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Qiu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Song P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., King KE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rastogi A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Janelsins B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinberg WC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Clouse K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Borders-Hemphill V; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Brown L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gomez-Broughton C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li Z; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Nguyen TT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Qiu Z; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ly AT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao T; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tu CM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., King-Kallimanis B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chiang K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lee C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Goldberg KB; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Leighton JK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 14; Vol. 28 (8), pp. 1487-1492.

Soy Phosphatidylinositol-Containing Lipid Nanoparticle Prolongs the Plasma Survival and Hemostatic Efficacy of B-domain-Deleted Recombinant Canine Factor VIII in Hemophilia A Dogs.

Autor: Shetty KA; Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York 14214., Merricks EP; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516., Raymer R; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516., Rigsbee N; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516., Nichols TC; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27516., Balu-Iyer SV; Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York 14214. Electronic address: svb@buffalo.edu.

Publikováno v: Journal of pharmaceutical sciences [J Pharm Sci] 2016 Aug; Vol. 105 (8), pp. 2459-64. Date of Electronic Publication: 2016 Jun 30.

Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Autor: Kosloski MP; Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, 359 Kapoor Hall, Buffalo, New York, 14214, USA., Shetty KA, Wakabayashi H, Fay PJ, Balu-Iyer SV

Publikováno v: The AAPS journal [AAPS J] 2014 Sep; Vol. 16 (5), pp. 1038-45. Date of Electronic Publication: 2014 Jun 17.

A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.

Autor: Karthikeyan SV; Department of Organic Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, India., Perumal S, Shetty KA, Yogeeswari P, Sriram D

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2009 Jun 01; Vol. 19 (11), pp. 3006-9. Date of Electronic Publication: 2009 Apr 14.